Aevis Victoria SA (SWX:AEVS)
Switzerland · Delayed Price · Currency is CHF 14.15
0.00 (0.00%)
Nov 12, 2026, 5:30 PM CET
Aevis Victoria Market Cap
Aevis Victoria has a market cap or net worth of 1.2 billion as of November 12, 2026. It is the 8,154th most valuable company in the world and the 112th biggest in Switzerland. Its market cap has increased by 11.28% in one year.
Market Cap
1.20B
Enterprise Value
2.19B
Revenue
1.05B
Global Rank
Country Rank
#112 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since July 5, 1999, Aevis Victoria's market cap has increased from 2.40M to 1.20B, an increase of 49,999.68%. That is a compound annual growth rate of 25.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 1.20B | 6.70% |
| Dec 30, 2025 | 1.13B | -10.38% |
| Dec 30, 2024 | 1.26B | -11.76% |
| Dec 29, 2023 | 1.42B | -3.64% |
| Dec 30, 2022 | 1.48B | 20.89% |
| Dec 30, 2021 | 1.22B | 17.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 320.53B |
| Novartis AG | 252.06B |
| Lonza Group AG | 46.06B |
| Galderma Group AG | 44.46B |
| SKAN Group AG | 1.56B |
| Medartis Holding AG | 1.35B |
| PolyPeptide Group AG | 1.33B |
| Idorsia | 1.12B |